Stock Yards Bank & Trust Co. Boosts Stock Position in CVS Health Corporation $CVS

Stock Yards Bank & Trust Co. lifted its holdings in CVS Health Corporation (NYSE:CVS) by 33.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,955 shares of the pharmacy operator’s stock after purchasing an additional 8,716 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in CVS Health were worth $2,411,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bell Investment Advisors Inc grew its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares in the last quarter. ORG Partners LLC grew its holdings in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares in the last quarter. Saudi Central Bank purchased a new position in CVS Health during the first quarter worth $34,000. Finally, Livelsberger Financial Advisory purchased a new position in CVS Health during the second quarter worth $35,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.1%

NYSE:CVS opened at $77.51 on Friday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $79.20. The company has a market cap of $98.31 billion, a price-to-earnings ratio of 21.65, a price-to-earnings-growth ratio of 0.85 and a beta of 0.60. The stock has a fifty day simple moving average of $70.71 and a 200-day simple moving average of $67.34. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the company earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is presently 74.30%.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Saturday, September 27th. Morgan Stanley lifted their price objective on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. Cowen reaffirmed a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Finally, Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $78.25.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.